Mirabaud & Cie Sa Eli Lilly & CO Transaction History
Mirabaud & Cie Sa
- $318 Million
- Q3 2025
A detailed history of Mirabaud & Cie Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Mirabaud & Cie Sa holds 12,695 shares of LLY stock, worth $11 Million. This represents 3.05% of its overall portfolio holdings.
Number of Shares
12,695
Previous 12,345
2.84%
Holding current value
$11 Million
Previous $9.62 Million
0.65%
% of portfolio
3.05%
Previous 3.03%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,470Shares Held
779MCall Options Held
16.9MPut Options Held
12.6M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$82.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$69.4 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$56.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44.3 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$29.8 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $820B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...